Start for free
Start for free
OO

Oncode Oncology Bridge Fund

Description

The Oncode Oncology Bridge Fund provides early stage financing to help the creation and growth of new enterprises

Investor Profile

Oncode Oncology Bridge Fund has made 1 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • The Netherlands (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oncode Oncology Bridge Fund frequently co-invest with?

Curie Capital
Curie Capital
North America, Missouri, United States, Netherlands
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
FF
Co-Investments: 1
Qbic Fund
Qbic Fund
North America, Wisconsin, United States, Belgium
Co-Investments: 1
Swanbridge Capital
Swanbridge Capital
Europe, Zuid-Holland, The Netherlands, Rotterdam
Co-Investments: 1
BOM
BOM
Europe, Noord-Brabant, The Netherlands, Tilburg
Co-Investments: 1
V-Bio Ventures
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 1

What are some of recent deals done by Oncode Oncology Bridge Fund?

Flindr Therapeutics

Amsterdam, Noord-Holland, The Netherlands

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

BiotechnologyHealth CareTherapeutics
Series AApr 24, 2024
Amount Raised: $21,400,056
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator